Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen Reiterates Buy Rating on Agios Pharma (AGIO)
-
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
-
Agios Pharma (AGIO) Named Best 2024 Idea at TD Cowen
-
Agios to Participate in March Investor Conferences
-
Agios to Participate in March Investor Conferences
-
Agios Pharma (AGIO) Named Best 2022 Idea at Cowen
-
Agios to Present at March Investor Conferences
-
Agios Pharma (AGIO) and Royalty Pharma Announce $255 Million Purchase Agreement for IDHIFA Royalty
-
Agios and Royalty Pharma Announce $255 Million Purchase Agreement for IDHIFA® Royalty
-
Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020
-
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Agios Pharma (AGIO) Prices 8.25M Share Common Offering at $31/Sh
-
Agios Announces Pricing of $256 Million Public Offering of Common Stock
-
Agios Pharma (AGIO) Announces Proposed Offering of Common Stock
-
Agios Announces Proposed Offering of Common Stock
-
Agios to Present at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019
-
Agios to Present at the Cowen 38th Annual Healthcare Conference Monday, March 12, 2018
-
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Agios Pharma (AGIO) Prices 7.1M Share Common Offering at $67/Sh
-
Agios Announces Pricing of $475 Million Public Offering of Common Stock
-
Agios Pharma (AGIO) Announces Proposed Max $400M Common Share Offering
-
Agios Announces Proposed Offering of Common Stock
-
Agios Announces Closing of Over-Allotment Option in Public Offering
-
Agios Announces Exercise of Over-Allotment Option in Public Offering
-
Agios Announces Closing of Public Offering
-
Agios Pharma (AGIO) Prices 5.05M Share Offering at $49.50/Sh
-
Agios Announces Pricing of $250 Million Public Offering of Common Stock
-
Agios Pharma (AGIO) Plans 4.5M Share Offering
-
Agios Announces Proposed Offering of Common Stock
-
Agios to Present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017
-
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Agios Pharma (AGIO) Prices 3.37M Share Common Stock Offering for Proceeds of ~$150M
-
Agios Announces Pricing of $150 Million Public Offering of Common Stock
-
Pre-Open Stock Movers 03/30: (ACAD) (VICL) (ANTM) Higher; (CTRV) (VRNT) (LNDC) Lower (more...)
-
Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8
-
Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
-
Agios Pharma (AGIO) Announces $175M Common Stock Offering
-
Pre-Open Stock Movers 9/26: (JNS) (NKE) (MU) Higher; (ACRX) (FINL) (BBRY) Lower (more...)
-
Notable Analyst Rating Changes 08/19: (INTC) (HUN) (DG) Upgraded; (FMD) (HK) (TRLA) Downgraded
-
Cowen Starts Agios Pharma (AGIO) at Outperform
-
Agios (AGIO) Files $86M IPO

